Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. The Company’s operations are structured into three business areas: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. The Anaesthesia business area offers a range of products such as resuscitators, face masks and laryngeal masks. The Patient Monitoring & Diagnostics business area comprises single use electrodes for cardiological and neurological examinations. The target groups for these products are hospitals, clinics, ambulance services and sleep labs. The Emergency Care business area offers ventilation bags, neck collars and manikins for first-aid training. The firm markets its products worldwide. The firm operates King Systems Inc, First Water Heathcote Ltd and Invendo Medical GmbH as subsidiaries.
How did AMBBY's recent EPS compare to expectations?
The most recent EPS for Ambu A/S is $0.46, not beating expectations of $0.5.
How did Ambu A/S AMBBY's revenue perform in the last quarter?
Ambu A/S revenue for the last quarter is $0.46
What is the revenue estimate for Ambu A/S?
According to 5 of Wall street analyst, the revenue estimate of Ambu A/S range from $1.74B to $1.6B
What's the earning quality score for Ambu A/S?
Ambu A/S has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Ambu A/S report earnings?
Ambu A/S next earnings report is expected in 2026-08-04
What are Ambu A/S's expected earnings?
Ambu A/S expected earnings is $1.64B, according to wall-street analysts.
Did Ambu A/S beat earnings expectations?
Ambu A/S recent earnings of $1.57B does not beat expectations.